Short-term effectiveness of baricitinib in children with refractory and/or severe juvenile dermatomyositis

OBJECTIVE: To determine the short-term effectiveness safety of baricitinib in children with refractory and/or severe juvenile dermatomyositis (rsJDM) in a real-world setting. METHODS: This was a single-center retrospective study, including 20 children with rsJDM. They were all treated using bariciti...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhaoling, Zheng, Qi, Xuan, Wenjie, Xu, Xisheng, Lu, Meiping, Wu, Jianqiang, Zou, Lixia, Xu, Yiping, Xu, Xuefeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9530147/
https://www.ncbi.nlm.nih.gov/pubmed/36204670
http://dx.doi.org/10.3389/fped.2022.962585

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9530147/
https://www.ncbi.nlm.nih.gov/pubmed/36204670
http://dx.doi.org/10.3389/fped.2022.962585

Ejemplares similares